Therapy of lymphoma inspired by functional and structural genomics
Wednesday Afternoon Lecture Series
Dr. Staudt's laboratory uses genomic technologies to discover molecular subtypes of cancer and develop therapies that target oncogenic regulatory pathways in each subtype. This endeavor is now commonly known as precision medicine and is the direct fruit of the Human Genome Project.
The Staudt laboratory has designed the " Lymphochip, " a custom DNA microarray that profiles gene expression in normal lymphocytes as well as in malignant lymphomas and leukemias. His laboratory defined two dominant molecular subtypes of the most common form of non-Hodgkin lymphoma – diffuse large B-cell lym...
Source: Videocast - All Events - January 30, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
